Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An overview of chemosensitivity testing.

Rosalyn D Blumenthal1

  • 1Garden State Cancer Center, Belleville, NJ, USA.

Methods in Molecular Medicine
|May 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types.

PPAR research·2008
Same author

Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts.

Radiation research·2007
Same author

Methods and goals for the use of in vitro and in vivo chemosensitivity testing.

Molecular biotechnology·2007
Same author

Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.

Anti-cancer drugs·2007
Same author

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

BMC cancer·2007
Same author

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).

Cancer research·2005
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Chemosensitivity testing is crucial for developing new cancer therapies and tailoring treatments. It helps predict how tumors respond to drugs, guiding personalized chemotherapy regimens for better patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Chemosensitivity testing is vital for advancing cancer therapy.
  • Understanding drug response patterns in various tumor types is essential.
  • Predicting cross-resistance and sensitivity in different disease stages is critical.

Purpose of the Study:

  • To highlight the significance of chemosensitivity testing in drug development and personalized medicine.
  • To review various assays used for chemosensitivity evaluation.
  • To discuss the correlation between in vitro, preclinical, and clinical outcomes.

Main Methods:

  • Overview of in vitro assays (clonogenic, proliferation, metabolic, molecular).
  • Description of in vivo assays (tumor growth, survival, imaging in metastatic and orthotopic models).

Related Experiment Videos

  • Discussion of molecular assays for responsiveness, resistance, and apoptosis markers.

    • Main Results:

    • Chemosensitivity testing aids in screening therapeutic agents.
    • Identifies drug sensitivity/resistance patterns and associated genomic/proteomic profiles.
    • Facilitates correlation of experimental results with clinical outcomes.

    Conclusions:

    • Various assays provide valuable data for chemosensitivity assessment.
    • Testing enables tailored chemotherapy regimens for individual patients.
    • Research in chemosensitivity testing is key to improving cancer treatment efficacy.